Dermatology focuses on the health of the skin, hair, and nails. Learn about the diagnosis and treatment of acne, eczema, skin cancer, and cosmetic procedures.
Send us all your questions or requests, and our expert team will assist you.
When it comes to treatment and procedures for vitiligo, patients often seek a blend of medical expertise and compassionate care. At Liv Hospital, our dedicated dermatology team combines cutting‑edge technology with individualized plans to address the unique challenges of this pigment‑loss condition. Over 1.5 million people worldwide are affected by vitiligo, and many experience significant psychological impact due to visible skin changes. This page provides a comprehensive overview of the therapeutic pathways available, from topical medicines to advanced surgical options, helping international patients understand what to expect and how to prepare for their journey toward repigmentation.
Whether you are newly diagnosed or have tried multiple approaches without success, the information below will guide you through evidence‑based treatment and procedures tailored to your skin type, disease extent, and personal goals. Our international patient services ensure seamless coordination of appointments, interpreter support, and accommodation, so you can focus on healing with confidence.
Vitiligo is an acquired skin disorder characterized by the loss of melanocytes, the cells responsible for producing pigment. The exact cause remains multifactorial, involving genetic susceptibility, autoimmune mechanisms, oxidative stress, and neural factors. While the condition is not harmful to physical health, its visible nature can lead to social stigma, reduced self‑esteem, and anxiety.
Key points to consider:
Understanding the underlying mechanisms helps clinicians select the most appropriate treatment and procedures. For example, patients with active autoimmune activity may benefit from systemic immunomodulators before undergoing phototherapy.
First‑line medical therapy aims to stabilize disease activity and stimulate repigmentation. Options include topical corticosteroids, calcineurin inhibitors, and vitamin D analogues. Systemic agents such as oral steroids, methotrexate, or Janus kinase (JAK) inhibitors are reserved for extensive or rapidly progressing cases.
Topical options:
Systemic therapies are monitored closely for side effects. Recent clinical trials have highlighted the promise of JAK inhibitors (e.g., tofacitinib, ruxolitinib) in achieving notable repigmentation, especially when paired with phototherapy.
Choosing the right regimen depends on disease extent, patient age, and tolerance. Liv Hospital’s dermatologists conduct thorough assessments to design a personalized plan that integrates these medical treatment and procedures with subsequent procedural steps when needed.
Phototherapy remains a cornerstone of vitiligo management, utilizing specific wavelengths of light to stimulate melanocyte activity. The most widely used modalities are narrowband UVB (NB‑UVB) and excimer laser (308 nm). Both are delivered in a controlled clinical setting, with treatment sessions typically scheduled two to three times per week.
Comparison of phototherapy modalities
In addition to phototherapy, laser-assisted pigment transplantation (e.g., fractional CO₂ laser) can create micro‑channels that enhance topical drug delivery, a technique often combined with melanocyte‑stimulating agents.
At Liv Hospital, our phototherapy units are calibrated to international standards, and treatment plans are adjusted based on skin type, lesion location, and patient response. These advanced treatment and procedures are delivered by board‑certified dermatologists with extensive experience in pigment disorders.
When medical and light‑based therapies reach a plateau, surgical options may offer a viable route to repigmentation. The most common techniques include melanocyte‑keratinocyte transplantation (MKTP), suction blister grafting, and split‑thickness skin grafting.
Overview of surgical methods:
Success rates vary, but many patients achieve >70 % repigmentation after a series of procedures. Pre‑operative assessment includes confirming disease stability (no new lesions for at least 6 months) and evaluating donor site availability.
Liv Hospital’s surgical dermatology unit follows strict aseptic protocols and employs state‑of‑the‑art microscopes to ensure precise graft placement. Post‑operative care includes topical steroids, phototherapy, and regular follow‑up to maximize outcomes of these specialized treatment and procedures.
Research into regenerative medicine has opened new horizons for vitiligo management. Autologous melanocyte stem cell transplantation and platelet‑rich plasma (PRP) injections are being investigated for their potential to rejuvenate the skin’s pigment‑producing capacity.
Key emerging modalities:
While these options are still largely experimental, Liv Hospital participates in international clinical studies, offering eligible patients access to cutting‑edge treatment and procedures under rigorous ethical oversight.
Traveling abroad for vitiligo care requires careful planning. Liv Hospital’s 360‑degree international patient service streamlines the process from the moment you inquire to the completion of follow‑up appointments.
Steps to a smooth experience:
Patients are advised to bring prior medical records, a list of current medications, and any relevant imaging. Our multidisciplinary team, which includes dermatologists, psychologists, and nutritionists, works together to address both the physical and emotional aspects of vitiligo.
Liv Hospital is a JCI‑accredited private facility in Istanbul, renowned for delivering world‑class care to international patients. Our dermatology department combines extensive experience in pigment disorders with access to the latest technologies, such as NB‑UVB phototherapy cabins and robotic‑assisted surgical suites. The hospital’s comprehensive patient services cover appointment scheduling, airport transfers, interpreter assistance, and comfortable accommodation options, allowing you to focus solely on your health journey.
Ready to begin your personalized vitiligo journey? Contact Liv Hospital today to schedule a confidential consultation and discover the most effective treatment and procedures tailored to your needs.
Take the first step toward renewed confidence—our international patient team is here to support you every step of the way.
Liv Hospital Ulus
Asst. Prof. MD. Ayşe Deniz Akkaya
Dermatology
Liv Hospital Ulus
Asst. Prof. MD. Nazlı Caf
Dermatology
Liv Hospital Ulus
Prof. MD. İlteriş Oğuz
Dermatology
Liv Hospital Ulus
Spec. MD. Ömer Gezdur
Dermatology
Liv Hospital Vadistanbul
Assoc. Prof. MD. Ece Altun
Dermatology
Liv Hospital Vadistanbul
Prof. MD. Sevilay Oğuz Kılıç
Dermatology
Liv Hospital Vadistanbul
Spec. MD. Marziyeh Javadpour
Dermatology
Liv Hospital Vadistanbul
Spec. MD. Meryem Ayşit
Dermatology
Liv Hospital Bahçeşehir
Assoc. Prof. MD. Nadir Göksügür
Dermatology
Liv Hospital Bahçeşehir
Spec. MD. Esengül Kaya
Dermatology
Liv Hospital Bahçeşehir
Spec. MD. Vedat Ertunç
Dermatology
Liv Hospital Bahçeşehir
Spec. MD. Özlem İpek
Dermatology
Liv Hospital Topkapı
Spec. MD. Betül Kızılkan
Dermatology
Liv Hospital Topkapı
Spec. MD. Gizem Gökçedağ Ünsal
Dermatology
Liv Hospital Ankara
Asst. Prof. MD. Caner Demircan
Dermatology
Liv Hospital Ankara
Spec. MD. Aylin Gözübüyükoğulları
Dermatology
Liv Hospital Ankara
Spec. MD. Elçin Akdaş
Dermatology
Liv Hospital Ankara
Spec. MD. Vahid Ahmadi
Dermatology
Liv Hospital Gaziantep
Spec. MD. Hatice Kübra Çakı
Dermatology
Liv Hospital Samsun
Asst. Prof. MD. Gül Şekerlisoy Tatar
Dermatology
Liv Hospital Samsun
Spec. MD. Ayşe İdil Baş
Dermatology
Liv Bona Dea Hospital Bakü
Spec. MD. İRFAN QEHREMANOV
Dermatology
Asst. Prof. MD. A. Deniz Akkaya
Dermatology
MD. Gül Şekerlisoy Tatar
Dermatology
Send us all your questions or requests, and our expert team will assist you.
The initial medical approach for vitiligo aims to stabilize disease activity and stimulate repigmentation. Topical corticosteroids reduce inflammation and can promote melanocyte migration, especially on limited patches. Calcineurin inhibitors such as tacrolimus are effective for facial lesions with a lower risk of skin atrophy. Vitamin D analogues provide modest repigmentation and are often combined with other agents. Systemic options like oral steroids, methotrexate, or JAK inhibitors are reserved for extensive or rapidly progressing cases and require close monitoring for side effects.
Narrowband UVB phototherapy delivers a specific wavelength of 311 nm light to the skin, which activates melanocytes and promotes the migration of pigment‑producing cells to depigmented areas. Treatments are typically administered two to three times per week for 12–24 weeks. The modality is well‑tolerated, making it suitable for large‑area vitiligo, and it can be combined with topical agents or systemic therapies to enhance outcomes. Side effects are generally mild, such as transient erythema, and long‑term risks are low compared with broadband UVB.
When vitiligo has been stable for at least six months, surgical interventions can be considered. Melanocyte‑keratinocyte transplantation (MKTP) harvests melanocytes from a donor site, expands them in culture, and applies them to depigmented lesions, offering high repigmentation rates for stable disease. Suction blister grafting creates epidermal blisters on donor skin and transfers them to the recipient area, ideal for small, well‑defined patches. Split‑thickness skin grafting transplants a thin layer of skin containing melanocytes and is used for larger, resistant lesions. Success rates often exceed 70 % repigmentation after a series of procedures, provided proper pre‑operative assessment and post‑operative care.
Regenerative medicine is exploring autologous melanocyte stem cell therapy, where stem cells are isolated from the patient’s skin, expanded in the laboratory, and re‑introduced into depigmented areas to achieve long‑term repigmentation. Platelet‑rich plasma (PRP) injections are also investigated for their growth‑factor content that may enhance melanocyte migration. While early trials show promise, these modalities remain experimental and are typically offered within clinical studies at centers like Liv Hospital, which participates in international research protocols under strict ethical oversight.
International patients benefit from a dedicated liaison team that arranges airport transfers, visa assistance, and hotel accommodations near the hospital. An initial tele‑medicine consultation allows the dermatology team to review medical history and set treatment goals. Professional interpreters are available for all in‑person appointments, ensuring clear communication. A personalized treatment schedule—including pre‑treatment labs, phototherapy, surgical procedures, and post‑procedure care—is created. After returning home, patients receive remote monitoring and virtual check‑ins to maintain continuity of care.
BlogDermatologyMar 17, 2026Concerned about a skin growth? Our dermatology specialists can confidently identify benign skin lesions and...
BlogDermatologyMar 19, 2026Vitiligo is a chronic autoimmune disease that affects 1-2% of the global population. It causes the loss of ...
BlogDermatologyMar 24, 2026Beau’s lines are horizontal grooves on a toddler’s nails. They can worry parents a lot. These n...
BlogDermatologyMar 17, 2026Restore your skin's natural appearance with expert dermatological care at Liv Hospital. Our specialists dia...
BlogDermatologyMar 16, 2026Children can get skin pigmentation from genes, the environment, and how they live. About 1% of newborns hav...
BlogDermatologyMar 17, 2026Uncover the causes and treatments for skin pigmentation disorders like vitiligo and melasma at Liv Hospital...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 510 67 91